TG Therapeutics ( (TGTX) ) has released its Q4 earnings. Here is a breakdown of the information TG Therapeutics presented to its investors.
TG Therapeutics, Inc. is a commercial-stage biopharmaceutical company specializing in the development and commercialization of novel treatments for B-cell diseases, with a focus on multiple sclerosis therapies.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com